Reports and Presentations

Gentian Diagnostics AS serves the global market with sensitive diagnostic tests. Current and pipeline products contribute to improved diagnostics and cost reductions in treatment of kidneys, inflammation, cardiovascular diseases, cancer and viral infections.


New call-to-action

 

On 14th December, 2016, Gentian Diagnostics AS was admitted to the Oslo Stock Exchange under GENT.

Find more information about the Gentian Share on Oslo Børs.
Learn more about Gentian Diagnostics AS here.

Financial Calendar 2021 

11TH FEB - QUARTERLY REPORT- Q4

16TH APR - ANNUAL REPORT

  • 16th April 2021 - Annual Report

16TH APR - QUARTERLY REPORT - Q1

  • 16th April 2021 - Quarterly Report - Q1
  • 16th April 2021 - Quarterly Presentation - Q1

4TH MAY - ANNUAL GENERAL MEETING

  • 4th May 2021 - AGM Minutes GD AS

25TH AUG - HALF-YEARLY REPORT

  • 25th August 2021 - Half-Yearly Report
  • 25th August 2021 - Half-Yearly Presentation

21ST OCT - QUARTERLY REPORT - Q3

  • 21st October 2021 - Quarterly Report - Q3
  • 21st October 2021 - Quarterly Presentation - Q3

 

Financial Calendar 2020

14TH FEB - QUARTERLY REPORT- Q4

24TH APR - ANNUAL REPORT

24TH APR - QUARTERLY REPORT - Q1

14TH MAY - ANNUAL GENERAL MEETING

21ST AUG - HALF-YEARLY REPORT

29TH OCT - QUARTERLY REPORT - Q3


14th of May 2020: Annual General Meeting

The 2020 Annual General Meeting of Gentian Diagnostics AS will be held on 14 May 2020 at 10:00 (CEST) at Bjørnåsveien 5, 1596 Moss.

Please find the notice incl. appendices enclosed here:

Historicals

Look at our historical archive to find financial reports and data from 2016-2019.